Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $1.94 billion. The enterprise value is $1.80 billion.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 32.54 million shares outstanding. The number of shares has increased by 8.22% in one year.
Current Share Class | n/a |
Shares Outstanding | 32.54M |
Shares Change (YoY) | +8.22% |
Shares Change (QoQ) | +1.98% |
Owned by Insiders (%) | 1.40% |
Owned by Institutions (%) | 0.69% |
Float | 14.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 12.29 |
P/TBV Ratio | 12.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 25.98
Current Ratio | 25.98 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,359.25 |
Financial Efficiency
Return on equity (ROE) is -33.43% and return on invested capital (ROIC) is -23.17%.
Return on Equity (ROE) | -33.43% |
Return on Assets (ROA) | -22.23% |
Return on Invested Capital (ROIC) | -23.17% |
Return on Capital Employed (ROCE) | -29.85% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.70M |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
Belite Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.22% |
Shareholder Yield | -8.22% |
Earnings Yield | -2.19% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Belite Bio is $96.67, which is 61.98% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $96.67 |
Price Target Difference | 61.98% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |